Cite
HARVARD Citation
He, A. et al. (n.d.). 73PCemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study. Annals of oncology. p. . [Online].